Indications for Percutaneous Endoscopic Gastrostomy (PEG) Tube
PEG feeding should be considered when a patient's nutritional intake is expected to be inadequate for a period exceeding 2-3 weeks, with the primary goal of improving or maintaining quality of life. 1
Primary Indications
Neurological Disorders (approximately 50% of cases)
- Dysphagia following cerebrovascular stroke or craniocerebral trauma 1
- Cerebral tumors 1
- Bulbar paralysis 1
- Parkinson's disease 1, 2
- Amyotrophic lateral sclerosis 1, 3
- Cerebral palsy 1
- Persistent vegetative state or slow recovering consciousness 1
Oncological Disorders (approximately 30% of cases)
- Stenosing tumors in the ear, nose, and throat region 1
- Upper gastrointestinal tract tumors 1
- Patients undergoing chemotherapy or radiotherapy with poor nutritional status 1
- Cancer cachexia 4
Other Clinical Conditions
- Wasting in AIDS 1
- Short bowel syndrome 1
- Reconstructive facial surgery 1
- Prolonged coma 1
- Polytrauma 1
- Crohn's disease 1
- Cystic fibrosis 1
- Chronic renal failure 1
- Congenital abnormalities (e.g., tracheo-esophageal fistula) 1
- Palliative drainage in chronic gastrointestinal stenosis or ileus 1
- Dementia (with careful consideration - not usually appropriate for advanced dementia) 1, 3
Decision-Making Algorithm
- Assess nutritional inadequacy: Determine if the patient will be unable to meet nutritional requirements orally for >2-3 weeks 1
- Try oral supplementation first: Attempt special nutritional drinks and swallowing therapy before considering PEG 1
- Evaluate prognosis and quality of life: PEG should improve or maintain quality of life 1
- Consider timing: Early PEG placement is recommended to prevent significant weight loss, as regaining lost weight is difficult even with optimal nutritional support 1
- Evaluate contraindications: Check for absolute contraindications including distal enteral obstruction, severe uncorrectable coagulopathy, and hemodynamic instability 5, 6
Important Considerations
- PEG placement should be for medical reasons, not administrative convenience or as a substitute for good nursing care 1
- PEG is generally not appropriate for patients with advanced cancer, end-stage diseases, or advanced dementia 1
- Early consideration of PEG is important as patients typically lose approximately 12kg of body weight in the 3 months before PEG placement is considered 1
- PEG tubes can remain in place for many years (>10 years) with proper care and do not require routine replacement 1
- For Parkinson's disease patients, special consideration must be given to medication-nutrition interactions when using standard PEG tubes 2
Benefits of PEG
- Improves nutritional status as evidenced by increases in body weight, mid-upper arm circumference, calf circumference, and serum albumin levels 3
- Associated with low complication rates (5.6% local insertion site infection, 1.1% systemic inflammatory symptoms) 3
- Better psychological tolerance than nasogastric tubes 4
- Can be performed without general anesthesia 4
- Cost-efficient with short hospitalization requirements 4
PEG is a safe, effective procedure that can significantly improve nutritional status and quality of life when appropriately indicated, but the decision should be made early in the disease course rather than as a last resort 1.